Evidence map›Paper›PMID 10438797›Full record

ArticleJournal of virology1999

Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism.

Y Yi, S N Isaacs, D A Williams, I Frank, D Schols, E De Clercq, D L Kolson, R G Collman

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Next generation sequencing reveals a high frequency of CXCR4 utilizing viruses in HIV-1 chronically infected drug experienced individuals in South Africa.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2018
    Article
  6. HIV-1 gp120Bal down-Regulates Phosphorylated NMDA Receptor Subunit 1 in Cortical Neurons via Activation of Glutamate and Chemokine Receptors.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2016
    Article
  7. Article
  8. Review
  9. Review
  10. Pathogenesis of HIV Infection.Infectious disease reports · 2013
    Review
  11. Article
  12. Article
  13. CD56+ T cells inhibit HIV-1 infection of macrophages.Journal of leukocyte biology · 2012
    Article
  14. Article
  15. Article
  16. Article
  17. Clinical significance of HIV-1 coreceptor usage.Journal of translational medicine · 2011
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Y YiDivisions of Pulmonary and Critical Care, Philadelphia, Pennsylvania, and Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium.
S N Isaacs
D A Williams
I Frank
D Schols
E De Clercq
D L Kolson
R G Collman
Pulmonary and Critical Care Associates · USOffice of Infectious Diseases · USUniversity of Pennsylvania · US

Funding

Dual-Tropic HIV-1 Strains and Primary Cell InfectionR01AI035502 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI COLLMAN, RONALD G · 1998 to 2009
$2.9M
HIV ACTIVATION &REGULATION IN LUNG--VIRAL DETERMINANTSR01HL058004 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI COLLMAN, RONALD G · 1996 to 2000
$278k
VACCINIA B5R PROTEIN IN DISSEMINATION AND IMMUNE EVASIONR29AI040957 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ISAACS, STUART N. · 1998 to 2001
$270k
HIV-1 VPR IN INFECTION OF PRIMARY MACROPHAGESR29AI035502 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI COLLMAN, RONALD G · 1994 to 1997
–
NHLBI NIH HHS HL 58004NIAID NIH HHS AI 35502NIAID NIH HHS AI 40957NIAID NIH HHS R01 AI035502NIAID NIH HHS R29 AI040957
6 · The paper itself

Abstract

Dual-tropic human immunodeficiency virus type 1 (HIV-1) strains infect both primary macrophages and transformed T-cell lines. Prototype T-cell line-tropic (T-tropic) strains use CXCR4 as their principal entry coreceptor (X4 strains), while macrophagetropic (M-tropic) strains use CCR5 (R5 strains). Prototype dual tropic strains use both coreceptors (R5X4 strains). Recently, CXCR4 expressed on macrophages was found to support infection by certain HIV-1 isolates, including the dual-tropic R5X4 strain 89.6, but not by T-tropic X4 prototypes like 3B. To better understand the cellular basis for dual tropism, we analyzed the macrophage coreceptors used for Env-mediated cell-cell fusion as well as infection by several dual-tropic HIV-1 isolates. Like 89.6, the R5X4 strain DH12 fused with and infected both wild-type and CCR5-negative macrophages. The CXCR4-specific inhibitor AMD3100 blocked DH12 fusion and infection in macrophages that lacked CCR5 but not in wild-type macrophages. This finding indicates two independent entry pathways in macrophages for DH12, CCR5 and CXCR4. Three primary isolates that use CXCR4 but not CCR5 (tybe, UG021, and UG024) replicated efficiently in macrophages regardless of whether CCR5 was present, and AMD3100 blocking of CXCR4 prevented infection in both CCR5 negative and wild-type macrophages. Fusion mediated by UG021 and UG024 Envs in both wild-type and CCR5-deficient macrophages was also blocked by AMD3100. Therefore, these isolates use CXCR4 exclusively for entry into macrophages. These results confirm that macrophage CXCR4 can be used for fusion and infection by primary HIV-1 isolates and indicate that CXCR4 may be the sole macrophage coreceptor for some strains. Thus, dual tropism can result from two distinct mechanisms: utilization of both CCR5 and CXCR4 on macrophages and T-cell lines, respectively (dual-tropic R5X4), or the ability to efficiently utilize CXCR4 on both macrophages and T-cell lines (dual-tropic X4).

Indexed as

Anti-HIV AgentsBenzylaminesCell FusionCells, CulturedCyclamsHeterocyclic CompoundsHIV-1HumansMacrophagesMonocytesReceptors, CCR5Receptors, CXCR4Viral Envelope ProteinsAnti-HIV AgentsBenzylaminesCyclamsHeterocyclic CompoundsplerixaforReceptors, CCR5Receptors, CXCR4Viral Envelope Proteins

Identifiers

PMID10438797
PMCPMC104231
OpenAlexW1490928025

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.